Danaher's growth has stabilized, with revenue expanding 5.5% in 2026Q2 after a cyclical trough, supported by resilient gross margins around 57.6% and strong cash conversion (OCF/NI of 1.76). The company is aggressively pursuing inorganic growth, allocating $9....
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth recovered to 5.5% in 2026Q2, with gross margin at 57.6% and operating margin at 18.0%, reflecting stabilization after a -19.8% contraction in 2024Q2.
Danaher is a leading global innovator in life sciences and diagnostics, committed to improving human health through science and technology.
The company has shown strong bioprocessing recovery, contributing to a 14.14% stock price appreciation since previous coverage.
Management's conservative 2026 guidance sets a baseline that could be exceeded, with projected high-single-digit EPS growth and 3-6% core revenue growth.
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 21, 2026 | $1.94+4.9% vs $1.85 | $6.3B+2.4% vs $6.1B |
Q2 2026 Apr 21, 2026 | $2.06+6.2% vs $1.94 | $6.0B-0.5% vs $6.0B |
Q1 2026 Jan 28, 2026 | $2.23+3.2% vs $2.16 | $6.8B+0.4% vs $6.8B |
Q4 2025 Oct 21, 2025 | $1.89+9.9% vs $1.72 | $6.1B+0.9% vs $6.0B |
WASHINGTON, Sept. 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2026 on Wednesday, October 21, 2026 beginning at 8:00 a.m.
Nykredit A S acquired a new position in shares of Danaher Corporation (NYSE: DHR) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 159,476 shares of the conglomerate's stock, valued at approximately $30,377,000. A number of other institutional investors and hedge funds
WASHINGTON, Sept. 15, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 30, 2026 to holders of record on September 30, 2026.
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
Benchmark DHR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Danaher Corporation (DHR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $221.12 | $155.44B | 43.87 | 2.9% | 14.71% | 7.08% | 0.56% | |
| $658.52 | $244.72B | 37.12 | 3.91% | 15.06% | 13.33% | — | |
| $167.25 | $47.24B | 36.60 | 6.73% | 19.53% | 20.47% | — | |
| $425.74 | $31.84B | 39.57 | 6.99% | 3.58% | 1.88% | — | |
| $379.57 | $10.22B | 13.62 | 0.65% | 8.59% | 3.15% | — | |
| $61.21 | $9.32B | -408.07 | 2.08% | -2.03% | -2.87% | — |
Danaher Corporation (DHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Danaher Corporation (DHR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 3, 2026·SEC
Jul 21, 2026·SEC
Jun 3, 2026·SEC
Get notified when DHR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Danaher Corporation (DHR) stock FAQ — growth, dividends, profitability & financials explained
Danaher Corporation (DHR) reported $25.11B in revenue for fiscal year 2025. This represents a 1286% increase from $1.81B in 1996.
Danaher Corporation (DHR) grew revenue by 2.9% over the past year. Growth has been modest.
Yes, Danaher Corporation (DHR) is profitable, generating $4.00B in net income for fiscal year 2025 (14.7% net margin).
Yes, Danaher Corporation (DHR) pays a dividend with a yield of 0.56%. This makes it attractive for income-focused investors.
Danaher Corporation (DHR) has a return on equity (ROE) of 7.1%. This is below average, suggesting room for improvement.
Danaher Corporation (DHR) generated $5.47B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
